Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.

Vaccines (Basel) · 2022 · PMC8880183 · PMID 35214692

Europe PMC DOI

hedged sentence

0.2466

closest p · 4.9× alpha

0.2466

boldest claim

The sentences

a small trendp = 0.2466not close (p > 0.1)

Under the same conditions, the rHBsAg G145R mutant added along with PHA had a small trend to increase the IFN-γ level relative to PHA (1.1 times, p = 0.2466), but this IFN-γ level was significantly higher compared with stimulation with the rHBsAg G145R mutant alone (1.8 times, p = 0.0337).

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.